Phenotypic Screening

• We conduct phenotypic screening using MEA assays, biomarker assays, and MPS assays. Samples are selected based on client needs from various models including human iPSC-derived neurons, glial cells, brain organoids, and spheroids. Cells provided by the client can also be utilized.

• Using multivariate analysis and AI analytics, we rank toxicity risks and make predictions based on the similarity to known compounds and mechanisms of action.